KROS – keros therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Keros Therapeutics (NASDAQ:KROS) had its price target raised by analysts at Bank of America Corporation from $18.00 to $19.00. They now have a "neutral" rating on the stock.
How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24% [Yahoo! Finance]
Keros Therapeutics Announces Final Results of Tender Offer [Yahoo! Finance]
Keros Therapeutics Announces Final Results of Tender Offer
Keros Therapeutics Announces Preliminary Results of Tender Offer
Form SC TO-I/A Keros Therapeutics, Inc. Filed by: Keros Therapeutics, Inc.
Form SC TO-I/A Keros Therapeutics, Inc. Filed by: Keros Therapeutics, Inc.
Form SCHEDULE 13G Keros Therapeutics, Inc. Filed by: ExodusPoint Capital Management, LP
Form 10-Q Keros Therapeutics, Inc. For: Sep 30
Form 8-K Keros Therapeutics, Inc. For: Nov 05
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.